Drug Channels

MARCH 1, 2022

The Centers for Medicare & Medicaid Services (CMS) has recently released its 2022 data on enrollment in Medicare Part D prescription drug plans (PDPs). Our exclusive analysis of these numbers finds that for 2022, an astounding 99% of seniors are enrolled in the wonderland of PDPs with preferred pharmacy networks.

Pharmacy 98

Pharmacy Marketing Drugs 98

Drug Channels

MARCH 8, 2022

Next week, Drug Channels Institute will release our 2022 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers. The total share of the largest 15 companies decreased slightly compared with their 2020 share, due primarily to below-market growth rates at retail and long-term care pharmacies.

Pharmacy 98

Pharmacy Marketing Drugs 98

Drug Channels

JUNE 12, 2024

The 340B contract pharmacy market shows little sign of slowing down. Drug Channels Institute’s exclusive analysis of the 2024 market reveals that: About 33,000 pharmacy locations—more than half of the entire U.S. For an updated look at what’s next for the 340B contract pharmacy market, join Adam J.

Pharmacy 52

Pharmacy Specialty Pharmacies Hospitals Marketing 52

Drug Channels

FEBRUARY 21, 2023

Pharmacies and Pharmacy Benefit Managers. Pharmacies and Pharmacy Benefit Managers is a definitive, nonpartisan resource that includes the most current information about pharmacy dispensing channels, third-party payers, pharmacy benefit managers (PBMs), patients’ financial contributions, government regulations, and much more.

Pharmacy 97

Pharmacy Specialty Pharmacies Licensing Licensing 97

Drug Channels

JANUARY 23, 2024

In a previous article , I highlighted the largest pharmacy chains that will participate in the 2024 Medicare Part D prescription drug plans (PDP). Plans from Aetna, Humana, WellCare, and UnitedHealthcare will not have any independent pharmacies participating via PSAOs as preferred pharmacies. Look out below!

Pharmacy 91

Pharmacy Independent Pharmacies Marketing Drugs 91

Drug Channels

JUNE 6, 2022

The retail pharmacy shakeout affected 2021 pharmacist employment. We found that retail pharmacies and drugstores employed fewer pharmacists, while hospitals and outpatient centers continued to add positions. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. Expect further declines as the shakeout continues.

Pharmacy 98

Pharmacy Hospitals Marketing Drugs 98

Drug Channels

MARCH 14, 2022

Asembia’s Specialty Pharmacy Summit 2022. May 2 – 5, 2022 | Las Vegas www.asembiasummit.com. Asembia's Specialty Pharmacy Summit 2022 is back! This is a must-attend event for anyone connected to specialty pharmacy. Read on for more details about this great specialty pharmacy event and register now.

Specialty Pharmacies 74

Specialty Pharmacies Pharmacy FDA Science 74

Drug Channels

AUGUST 6, 2024

In the video excerpt below, I walk through a brief history of 340B contract pharmacies. I conclude with a “follow the dollar” example of 340B prescription economics with contract pharmacies. If this clip whets your appetite for more, register to watch a replay of the full 90-minute video webinar from June. All rights reserved.

Pharmacy 52

Pharmacy Hospitals Marketing Drugs 52

Drug Channels

JULY 20, 2022

In this issue: CVS disassociates itself from its chain pharmacy association Payers are paying attention to ICER Benefits of the biosimilar boom A fantastic takedown of health insurance deductibles Plus, I join the Advisory Board of Alto Pharmacy. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. to 1:30 p.m.

Biosimilars 98

Biosimilars Pharmacy Drugs Marketing 98

Drug Channels

MARCH 1, 2022

The Centers for Medicare & Medicaid Services (CMS) has recently released its 2022 data on enrollment in Medicare Part D prescription drug plans (PDPs). Our exclusive analysis of these numbers finds that for 2022, an astounding 99% of seniors are enrolled in the wonderland of PDPs with preferred pharmacy networks.

Pharmacy 98

Pharmacy Marketing Drugs 98

Drug Channels

APRIL 26, 2022

In this issue: Green Monster : The 340B market hits new highs in 2021 Not-Free Agents : Big 340B profits for CVS, Walgreens, Express Scripts, et al Batter Up : Fixing the insulin market Pinch Hitters : Walgreens bets on robots Plus, Dr. Glaucomflecken helps UnitedHealthcare celebrate Doctors’ Day! Hope to see you there!

Pharmacy 98

Pharmacy Specialty Pharmacies Doctors Drugs 98

Drug Channels

MARCH 14, 2023

Pharmacies and Pharmacy Benefit Managers , available for purchase and immediate download. Prescription Market (press release) We’re offering special discounted pricing if you order before April 3, 2023. Prescription Market (press release) We’re offering special discounted pricing if you order before April 3, 2023.

Pharmacy 98

Pharmacy Drugs Marketing Biosimilars 98

Drug Channels

OCTOBER 24, 2023

Our exclusive analysis of Center for Medicare & Medicaid Services’ (CMS) data reveals that preferred cost sharing pharmacy networks will maintain their dominance as a component of Part D benefit design. In upcoming articles, I’ll delve into chain and independent pharmacies’ participation in the major 2024 preferred networks.

Pharmacy 52

Pharmacy Independent Pharmacies Marketing Drugs 52

Drug Channels

MARCH 27, 2023

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Discount Cards, Cost-Plus Pharmacies, and PBMs: Trends, Controversies, and Outlook. Click here to see the original post and comments from November 2022. Click here to see the original post and comments from November 2022.

Pharmacy 98

Pharmacy Marketing Drugs 98

Drug Channels

NOVEMBER 15, 2022

The rise of discount card pricing within pharmacy benefit plans is a positive development. Patients get access to market prices that can be lower than their PBM’s contracted rate. I’ll cover what’s next for PBMs and discount cards during my upcoming live video webinar, Drug Channels Outlook 2023 , on December 16, 2022, from 12:00 p.m.

Pharmacy 98

Pharmacy Marketing Drugs 98

Drug Channels

DECEMBER 12, 2022

Click here to see the original post and comments from September 2022. By now, you have already read innumerable articles explaining what’s in the new Inflation Reduction Act of 2022 (IRA; P.L. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

Biosimilars 98

Biosimilars Pharmacy Hospitals Marketing 98

Drug Channels

SEPTEMBER 13, 2022

By now, you have already read innumerable articles explaining what’s in the new Inflation Reduction Act of 2022 (IRA; P.L. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. Today, I want to highlight three significant—and presumably unintended—drug channel consequences from the hastily-passed IRA legislation.

Biosimilars 97

Biosimilars Pharmacy Hospitals Marketing 97

Drug Channels

NOVEMBER 29, 2022

In this issue: Mark Cuban schools Elon Musk on PBMs Market access lessons from Semglee Gen Z rejects the pharmacy career path A potent call for 340B transparency Plus, get ready to love the ‘90s again! Please join me for my upcoming live video webinar, Drug Channels Outlook 2023 , on December 16, 2022, from 12:00 p.m.

Pharmacy 97

Pharmacy Drugs Marketing Biosimilars 97

Drug Channels

NOVEMBER 16, 2021

In Consolidation and Preferred Pharmacy Networks in 2022’s Medicare Part D Plans , I highlighted how those networks have hijacked the world of stand-alone Medicare Part D prescription drug plans (PDP) and become a major presence in Medicare Advantage prescription drug (MA-PD) plans. to 1:30 p.m. Click here to learn more and sign up.

Pharmacy 98

Pharmacy Marketing Drugs 98

Drug Channels

MARCH 11, 2022

Today’s guest post comes from Stacey Little, Senior Vice President of Business Development and Marketing at AssistRx. Learn more about AssistRx’s specialty therapy initiation and patient support services at Asembia's Specialty Pharmacy Summit on May 2-5, 2022. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc.

Specialty Pharmacies 97

Specialty Pharmacies Pharmacy Therapies Marketing 97

Drug Channels

JULY 25, 2022

Click here to see the original post from April 2022. The highly-consolidated PBM market notched another year of increased concentration. Consider Drug Channels Institute's latest estimates of pharmacy benefit manager (PBM) market share, shown in the chart below. d/b/a Drug Channels Institute.

Pharmacy 98

Pharmacy Marketing Drugs 98

Drug Channels

JULY 11, 2022

Informa Connect's Hub and Specialty Pharmacy Models West. September 14-15, 2022 Sheraton San Diego Hotel & Marina | San Diego, CA www.informaconnect.com/hub-specialty-pharmacy-west. Copyright © 2006-2022 Pembroke Consulting, Inc. Delivered as a Hybrid Event. Drug Channels, or any of its employees.

Specialty Pharmacies 98

Specialty Pharmacies Pharmacy Biosimilars Compliance 98

Drug Channels

JANUARY 21, 2022

Today’s guest post comes from Chris Dowd, Senior Vice President of Market Development at ConnectiveRx. Chris discusses how COVID-19 is impacting stakeholders across the healthcare system, including patients, providers, pharmacies, and manufacturers. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc.

Pharmacy 98

Pharmacy Marketing Drugs 98

Drug Channels

MAY 24, 2022

As the market for patient-paid prescriptions has expanded, disputes about the appropriate split of these spreads will pressure pharmacy-PBM relationships and drive change in the discount card business model. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. Read on and see what you think. d/b/a Drug Channels Institute.

Pharmacy 98

Pharmacy Marketing Drugs 98

Drug Channels

APRIL 5, 2022

The highly-consolidated PBM market notched another year of increased concentration. Consider Drug Channels Institute's latest estimates of pharmacy benefit manager (PBM) market share, shown in the chart below. Significant business relationships among the largest companies continue to shift market share.

Pharmacy 98

Pharmacy Marketing Drugs 98

Drug Channels

MAY 9, 2022

Informa Connect’s Hub and Specialty Pharmacy Models East. June 28-30, 2022 | Sheraton Parsippany | Parsippany, NJ www.informaconnect.com/hub-specialty-pharmacy. For 2022 only, Hub and Specialty Pharmacy Models and PAP – Patient Assistance & Access Programs are under the same roof. Delivered as a Hybrid Event.

Specialty Pharmacies 75

Specialty Pharmacies Pharmacy Pharmaceuticals Government 75

FDA Law Blog: Biosimilars

AUGUST 21, 2023

Attorney’s Office for the Western District of Texas announced that People’s Rx, a local chain operating five retail pharmacies and a compounding laboratory in the Austin area, agreed to pay $200,000 to settle allegations that it violated the Controlled Substances Act (“CSA”). 16, 2023 ( DOJ Press Release ). 2, 2020 ( DOJ Press Release ).

Pharmacy 52

Pharmacy Regulations Production Laboratories 52

Drug Channels

MARCH 5, 2024

WHAT YOU WILL LEARN In 2023, the Inflation Reduction Act of 2022 (IRA) began to alter the Medicare Part D program and trigger changes in beneficiary out-of-pocket spending, drug prices, pharmacy economics, and market access strategies. Pharmacies and Pharmacy Benefit Managers.

Pharmacy 98

Pharmacy Biosimilars Drugs Marketing 98

Drug Channels

APRIL 4, 2023

We estimate that the gross-to-net bubble reached $223 billion for patent-protected brand-name drugs in 2022. Four crucial trends will deflate the gross-to-net bubble—thereby disrupting market access strategies, altering pharmacy benefit manager (PBM) profit models, and changing plan sponsor benefit designs.

Marketing 75

Marketing Pharmacy Drugs 75

Drug Channels

DECEMBER 15, 2022

Click here to see the original post and comments from October 2022. Below, I highlight three unexpected findings from the data regarding GoodRx’s market position, when people use discount cards, how much they save, and why PBMs should still be worried about this market. Link below.) d/b/a Drug Channels Institute.

Marketing 98

Marketing Research Drugs Pharmacy 98

Drug Channels

JUNE 21, 2023

We estimate that the gross-to-net bubble reached $223 billion for patent-protected brand-name drugs in 2022. Four crucial trends will deflate the gross-to-net bubble—thereby disrupting market access strategies, altering pharmacy benefit manager (PBM) profit models, and changing plan sponsor benefit designs.

Marketing 75

Marketing Pharmacy Drugs 75

Drug Channels

NOVEMBER 15, 2021

Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new live video webinar: Drug Channels Outlook 2022. The Outlook 2022 marks our third annual outlook webinar. Broadcast live on December 17, 2021. to 1:30 p.m.

Specialty Pharmacies 94

Specialty Pharmacies Biosimilars Pharmacy Drugs 94

Drug Channels

APRIL 18, 2023

Like it or not, the Centers for Medicare & Medicaid Services (CMS) is barreling ahead with its implementation of the Inflation Reduction Act of 2022 (IRA). Last Friday was the last day to submit comments on CMS's initial guidance on the drug price negotiation program.

Marketing 98

Marketing Pharmacy Drugs 98

Drug Channels

DECEMBER 6, 2022

In Preferred Pharmacy Networks in 2023’s Medicare Part D Plans: Cigna, CVS Health, Humana, UnitedHealthcare, WellCare, and More , I highlighted how those networks have taken over the world of stand-alone Medicare Part D prescription drug plans (PDP) and become a major presence in Medicare Advantage prescription drug (MA-PD) plans.

Pharmacy 98

Pharmacy Marketing Drugs 98

Drug Channels

JUNE 20, 2023

Like it or not, the Centers for Medicare & Medicaid Services (CMS) is barreling ahead with its implementation of the Inflation Reduction Act of 2022 (IRA). Click here to see the original post from April 2023. Last Friday was the last day to submit comments on CMS's initial guidance on the drug price negotiation program.

Marketing 98

Marketing Pharmacy Drugs 98

Drug Channels

OCTOBER 4, 2022

Below, I highlight three unexpected findings from the data regarding GoodRx’s market position, when people use discount cards, how much they save, and why PBMs should still be worried about this market. There’s a lot to unpack about the growing discount card market. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc.

Marketing 98

Marketing Research Drugs Pharmacy 98

Drug Channels

OCTOBER 11, 2022

I am pleased to announce our new 2022–23 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , available for purchase and immediate download. Drug Distribution Industry Expands as COVID-19 Disruption Fades and Biosimilars Boom (press release) We’re offering special discounted pricing if you order before October 21, 2022!

Pharmaceuticals 74

Pharmaceuticals Biosimilars Licensing Licensing 74